Adherence to Antihypertensive Treatment and the Blood Pressure Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
CONCLUSIONS: -In the DENERHTN trial, the prevalence of non-adherence to antihypertensive drugs at 6 months was high (≈50%) but not different in the renal denervation and control groups. Regardless of adherence to treatment, renal denervation plus standardized stepped-care antihypertensive treatment resulted in a greater decrease in blood pressure than standardized stepped-care antihypertensive treatment alone. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01570777.
PMID: 27576780 [PubMed - as supplied by publisher]
Source: Circulation - Category: Cardiology Authors: Azizi M, Pereira H, Hamdidouche I, Gosse P, Monge M, Bobrie G, Delsart P, Mounier-Véhier C, Courand PY, Lantelme P, Denolle T, Dourmap-Collas C, Girerd X, Halimi JM, Zannad F, Ormezzano O, Vaisse B, Herpin D, Ribstein J, Chamontin B, Mourad JJ, Ferrari E Tags: Circulation Source Type: research
More News: Avapro | Bisoprolol | Cardiology | Clinical Trials | Hypertension | Indapamide | Norvasc | Spironolactone